ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT02773849 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Superficial Bladder Cancer

Interventions

BIOLOGICAL: ADSTILADRIN

Sponsor

Ferring Pharmaceuticals

Collaborators

[object Object]
[object Object]